Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

Al‐Batran, Salah‐Eddin; Homann, Nils; Pauligk, Claudia; Illerhaus, Gerald; M. Martens, Uwe; Stoehlmacher, Jan; Schmalenberg, Harald; Barbara Luley, Kim; Prasnikar, Nicole; Egger, Matthias; Probst, Stephan; Messmann, Helmut; Moehler, Markus; Fischbach, Wolfgang; T. Hartmann, Jörg; Mayer, Frank; Höffkes, Heinz‐Gert; Koenigsmann, Michael; Arnold, Dirk; Kraus, Thomas; Grimm, Kersten; Berkhoff, Stefan; Post, Stefan; Jäger, Elke; O. Bechstein, Wolf; Ronellenfitsch, Ulrich; Mönig, Stefan; Hofheinz, Ralf‐Dieter

doi:10.1001/jamaoncol.2017.0515

Public

Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer

Published in JAMA Oncology • Apr 27, 2017

Authors:

Salah‐Eddin Al‐Batran

Nils Homann

Claudia Pauligk

Abstract

IMPORTANCE: Surgical resection has a potential benefit for patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction. OBJECTIVE: To evaluate outcome in patients with limited metastatic disease who receive chemotherapy first and proceed to surgical resection. DESIGN, SETTIN...

Subject

Medicine

Docetaxel

Oxaliplatin

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!